Aktienkurs
25.67
Täglich Wechseln
0.83 3.34%
Monatlich
33.77%
Jährlich
42.37%
Q2 Prognose
25.12




Umlaufvermögen Veränderung Datum
Abbott USD 26B 1.16B 2025-12
Bausch Health Companies USD 6.16B 92M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Cerus USD 167.13M 1.41M 2025-09
Cooper Companies USD 2.13B 27.4M 2025-12
J&J USD 59.17B 3.55B 2026-03
Merit Medical Systems USD 1.04B 54.62M 2025-12
Novartis USD 30.46B 2.26B 2025-12
OraSure Technologies USD 261.91M 21.1M 2025-12
Orthofix International USD 416.85M 22.68M 2025-12
Rockwell Medical USD 31.61M 1.42M 2025-06
STAAR Surgical USD 311.54M 9.66M 2025-12
Utah Medical Products USD 97.74M 1.21M 2025-12